J. Kaufman, J. Cohen, M. Peredo, B. Jonas, A. Nogueira, and J. H. Mashburn, “Two On-Label Injection Volumes of AbobotulinumtoxinA (ABO) Produce Simlar Safety and Efficacy Results when Used to Treate Moderate to Sever Glabellar Lines”, J of Skin, vol. 1, no. 3.1, p. s91, Oct. 2017.